Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Laura Feetham
Guest Post - Ghost-writing Peer Reviews Should Be a Thing of the Past
Editor’s Note: Today’s post is by Laura Feetham. Laura is Reviewer Engagement Manager at IOP Publishing. Ghost-writing peer review reports is fundamentally flawed and detrimental to the principles of academic integrity and intellectual honesty. It obscures reviewers’ true contributions and potentially misrepresents the expertise of the individuals involved. Depriving reviewers credit for their reviews perpetuates a culture in which deserving individuals are denied recognition for their hard work.
Guest Post — Ghost-writing Peer Reviews Should Be a Thing of the Past - Book Business
Policies that formally give peer reviewers the option to officially invite a colleague to collaborate with them improve integrity, transparency, and offers a chance to give fair credit where it is due. The post Guest Post — Ghost-writing Peer Reviews Should Be a Thing of the Past appeared first on The Scholarly Kitchen.
Pancreatic cancer
Executive Summary Pancreatic cancer is an intractable disease that often evades early diagnosis and defies treatment. The global incidence of pancreatic cancer in 2017 was 5·7 per 100 000 person-years, up from 5·0 per 100 000 person-years in 1990; deaths have also increased during this time period from 196 000 to 441 000. Pancreatic cancer also has one of the highest mortality-to-incidence ratios of any solid tumour.
Working together to reduce the burden of pancreatic cancer
1 GBD 2017 Pancreatic Cancer Collaborators The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study. Lancet Gastroenterol Hepatol. 2019; 4 : 934-947 Pancreatic cancer has one of the highest mortality-to-incidence ratios of any solid tumour.
Digestive Disease Week 2019
Mirikizumab—a monoclonal antibody that binds the p19 subunit of interleukin 23—resulted in improvements in endoscopic findings for patients with Crohn's disease, according to phase 2 data presented by Bruce Sands (New York, NY, USA) and colleagues. Patients with moderate-to-severe active Crohn's disease were randomly assigned to receive mirikizumab at 200 mg (n=31), 600 mg (n=32), 1000 mg (n=64), or placebo (n=64) for a 12-week induction period.
Black Country Lungs: a moving exploration of COPD in a post-industrial community
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figures“My lungs, they said, are like a colander. I had it all checked out. I went to the hospital and had a full MOT. It's asbestos-related, because that's what it does to you; it breaks down the tissues or something. I was a welder. I started work when I was 15 and they said the smoking might also have contributed. I've smoked since I was 11. I have stopped now.
The long road to recovery after the ICU
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figures“I just thought as soon as I got out of the hospital and into my own home I would get back to my life again, but it didn't work that way”. On Nov 15, 2016, Alice Hoy's life changed dramatically; although she woke up feeling ok, she was rushed to hospital only hours later with severe sepsis caused by a double-strangulated hernia.
A thousand words: a photographic exploration of global respiratory health
Tezacaftor–ivacaftor is safe and efficacious in patients with cystic fibrosis with Phe508del mutations
Respiratory medicine and critical care: a call for papers for ERS
A new chapter for the NCD Alliance: stronger together
Respiratory medicine and critical care: a call for papers for ERS
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresThe Lancet and The Lancet Respiratory Medicine would like to hear from authors of research papers in the fields of respiratory medicine and critical care, as the two journals are planning special issues to coincide with the 2017 European Respiratory Society conference taking place in Milan, Italy, from Sept 9–13, 2017.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Laura
Contact Laura, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack